105 related articles for article (PubMed ID: 27702664)
41. Aromatase is phosphorylated in situ at serine-118.
Miller TW; Shin I; Kagawa N; Evans DB; Waterman MR; Arteaga CL
J Steroid Biochem Mol Biol; 2008 Nov; 112(1-3):95-101. PubMed ID: 18822378
[TBL] [Abstract][Full Text] [Related]
42. In vitro kinetic properties of the Thr201Met variant of human aromatase gene CYP19A1: functional responses to substrate and product inhibition and enzyme inhibitors.
Payne EJ; Ingley E; Dick IM; Wilson SG; Bond CS; Prince RL
J Clin Endocrinol Metab; 2009 Aug; 94(8):2998-3002. PubMed ID: 19470632
[TBL] [Abstract][Full Text] [Related]
43. In situ estrogen production and its regulation in human breast carcinoma: from endocrinology to intracrinology.
Sasano H; Miki Y; Nagasaki S; Suzuki T
Pathol Int; 2009 Nov; 59(11):777-89. PubMed ID: 19883428
[TBL] [Abstract][Full Text] [Related]
44. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H
Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110
[TBL] [Abstract][Full Text] [Related]
45. Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.
Chen D; Reierstad S; Lin Z; Lu M; Brooks C; Li N; Innes J; Bulun SE
Cancer Res; 2007 Sep; 67(18):8914-22. PubMed ID: 17875734
[TBL] [Abstract][Full Text] [Related]
46. Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system.
Chimento A; Sirianni R; Zolea F; De Luca A; Lanzino M; Catalano S; Andò S; Pezzi V
J Cell Physiol; 2012 May; 227(5):2079-88. PubMed ID: 21769864
[TBL] [Abstract][Full Text] [Related]
47. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
Prosperi JR; Robertson FM
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
[TBL] [Abstract][Full Text] [Related]
48. Molecular basis for the interaction of four different classes of substrates and inhibitors with human aromatase.
Hong Y; Cho M; Yuan YC; Chen S
Biochem Pharmacol; 2008 Mar; 75(5):1161-9. PubMed ID: 18184606
[TBL] [Abstract][Full Text] [Related]
49. Structural basis for the functional roles of critical residues in human cytochrome p450 aromatase.
Lo J; Di Nardo G; Griswold J; Egbuta C; Jiang W; Gilardi G; Ghosh D
Biochemistry; 2013 Aug; 52(34):5821-9. PubMed ID: 23899247
[TBL] [Abstract][Full Text] [Related]
50. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
51. Retinol inhibits aromatase activity and expression in vitro.
Ciolino HP; Dai Z; Nair V
J Nutr Biochem; 2011 Jun; 22(6):522-6. PubMed ID: 20685100
[TBL] [Abstract][Full Text] [Related]
52. Molecular mechanisms of aromatase inhibition by new A, D-ring modified steroids.
Cepa M; Correia-da-Silva G; Tavares da Silva EJ; Roleira FM; Hong Y; Chen S; Teixeira NA
Biol Chem; 2008 Sep; 389(9):1183-91. PubMed ID: 18713005
[TBL] [Abstract][Full Text] [Related]
53. Triiodothyronine decreases the activity of the proximal promoter (PII) of the aromatase gene in the mouse Sertoli cell line, TM4.
Catalano S; Pezzi V; Chimento A; Giordano C; Carpino A; Young M; McPhaul MJ; Andò S
Mol Endocrinol; 2003 May; 17(5):923-34. PubMed ID: 12586841
[TBL] [Abstract][Full Text] [Related]
54. The human glutathione S-transferase P1 protein is phosphorylated and its metabolic function enhanced by the Ser/Thr protein kinases, cAMP-dependent protein kinase and protein kinase C, in glioblastoma cells.
Lo HW; Antoun GR; Ali-Osman F
Cancer Res; 2004 Dec; 64(24):9131-8. PubMed ID: 15604283
[TBL] [Abstract][Full Text] [Related]
55. Functional characterization of 102-amino acid-deleted form of human aromatase (delta102-aromatase).
Kao YC; Higashiyama T; Yarborough C; Osawa Y; Chen S
Steroids; 1999 Jun; 64(6):422-9. PubMed ID: 10433179
[TBL] [Abstract][Full Text] [Related]
56. Structure-function studies of human aromatase.
Chen S; Zhou D; Swiderek KM; Kadohama N; Osawa Y; Hall PF
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):347-56. PubMed ID: 8476748
[TBL] [Abstract][Full Text] [Related]
57. Study of substrate specificity of human aromatase by site directed mutagenesis.
Auvray P; Nativelle C; Bureau R; Dallemagne P; Séralini GE; Sourdaine P
Eur J Biochem; 2002 Mar; 269(5):1393-405. PubMed ID: 11874453
[TBL] [Abstract][Full Text] [Related]
58. Human and quail aromatase activity is rapidly and reversibly inhibited by phosphorylating conditions.
Charlier TD; Harada N; Balthazart J; Cornil CA
Endocrinology; 2011 Nov; 152(11):4199-210. PubMed ID: 21914772
[TBL] [Abstract][Full Text] [Related]
59. Working at the membrane interface: Ligand-induced changes in dynamic conformation and oligomeric structure in human aromatase.
Di Nardo G; Cimicata G; Baravalle R; Dell'Angelo V; Ciaramella A; Catucci G; Ugliengo P; Gilardi G
Biotechnol Appl Biochem; 2018 Jan; 65(1):46-53. PubMed ID: 28926141
[TBL] [Abstract][Full Text] [Related]
60. Depicting the proton relay network in human aromatase: New insights into the role of the alcohol-acid pair.
Zhang C; Gilardi G; Di Nardo G
Protein Sci; 2022 Sep; 31(9):e4389. PubMed ID: 36040260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
